Literature DB >> 15932872

Crystal structure of Kunitz domain 1 (KD1) of tissue factor pathway inhibitor-2 in complex with trypsin. Implications for KD1 specificity of inhibition.

Amy E Schmidt1, Hitendra S Chand, Dulio Cascio, Walter Kisiel, S Paul Bajaj.   

Abstract

Kunitz domain 1 (KD1) of tissue factor pathway inhibitor-2 inhibits trypsin, plasmin, and factor VIIa (FVIIa)/tissue factor with Ki values of 13, 3, and 1640 nM, respectively. To investigate the molecular specificity of KD1, crystals of the complex of KD1 with bovine beta-trypsin were obtained that diffracted to 1.8 A. The P1 residue Arg-15 (bovine pancreatic trypsin inhibitor numbering) in KD1 interacts with Asp-189 (chymotrypsin numbering) and with the carbonyl oxygens of Gly-219 and Ogamma of Ser-190. Leu-17, Leu-18, Leu-19, and Leu-34 in KD1 make van der Waals contacts with Tyr-39, Phe-41, and Tyr-151 in trypsin, forming a hydrophobic interface. Molecular modeling indicates that this complementary hydrophobic patch is composed of Phe-37, Met-39, and Phe-41 in plasmin, whereas in FVIIa/tissue factor, it is essentially absent. Arg-20, Tyr-46, and Glu-39 in KD1 interact with trypsin through ordered water molecules. In contrast, insertions in the 60-loop in plasmin and FVIIa allow Arg-20 of KD1 to directly interact with Glu-60 in plasmin and Asp-60 in FVIIa. Moreover, Tyr-46 in KD1 electrostatically interacts with Lys-60A and Arg-60D in plasmin and Lys-60A in FVIIa. Glu-39 in KD1 interacts directly with Arg-175 of the basic patch in plasmin, whereas in FVIIa, such interactions are not possible. Thus, the specificity of KD1 for plasmin is attributable to hydrophobic and direct electrostatic interactions. For trypsin, hydrophobic interactions are intact, and electrostatic interactions are weak, whereas for FVIIa, hydrophobic interactions are missing, and electrostatic interactions are partially intact. These findings provide insight into the protease selectivity of KD1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932872     DOI: 10.1074/jbc.M504105200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Anti-inflammatory actions of serine protease inhibitors containing the Kunitz domain.

Authors:  Hiroshi Shigetomi; Akira Onogi; Hirotaka Kajiwara; Shozo Yoshida; Naoto Furukawa; Shoji Haruta; Yasuhito Tanase; Seiji Kanayama; Taketoshi Noguchi; Yoshihiko Yamada; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Inflamm Res       Date:  2010-05-08       Impact factor: 4.575

2.  Weak conservation of structural features in the interfaces of homologous transient protein-protein complexes.

Authors:  Govindarajan Sudha; Prashant Singh; Lakshmipuram S Swapna; Narayanaswamy Srinivasan
Journal:  Protein Sci       Date:  2015-09-08       Impact factor: 6.725

3.  Three-dimensional Structure of a Kunitz-type Inhibitor in Complex with an Elastase-like Enzyme.

Authors:  Rossana García-Fernández; Markus Perbandt; Dirk Rehders; Patrick Ziegelmüller; Nicolas Piganeau; Ulrich Hahn; Christian Betzel; María de Los Ángeles Chávez; Lars Redecke
Journal:  J Biol Chem       Date:  2015-04-15       Impact factor: 5.157

4.  Expression, purification, crystallization and preliminary X-ray diffraction analysis of Sagittaria sagittifolia arrowhead protease inhibitor API-A in complex with bovine trypsin.

Authors:  Chunhui Jiang; Rui Bao; Yuxing Chen
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-10-31

5.  The ternary structure of the double-headed arrowhead protease inhibitor API-A complexed with two trypsins reveals a novel reactive site conformation.

Authors:  Rui Bao; Cong-Zhao Zhou; Chunhui Jiang; Sheng-Xiang Lin; Cheng-Wu Chi; Yuxing Chen
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

6.  Identification and anticoagulant activity of a novel Kunitz-type protein HA11 from the salivary gland of the tick Hyalomma asiaticum.

Authors:  Houshuang Zhang; Ruiqiong Qiao; Haiyan Gong; Jie Cao; Yongzhi Zhou; Jinlin Zhou
Journal:  Exp Appl Acarol       Date:  2017-01-13       Impact factor: 2.132

7.  S2'-subsite variations between human and mouse enzymes (plasmin, factor XIa, kallikrein) elucidate inhibition differences by tissue factor pathway inhibitor -2 domain1-wild-type, Leu17Arg-mutant and aprotinin.

Authors:  K Vadivel; Y Kumar; G I Ogueli; S M Ponnuraj; P Wongkongkathep; J A Loo; M S Bajaj; S P Bajaj
Journal:  J Thromb Haemost       Date:  2016-11-19       Impact factor: 5.824

8.  Comparative effects of aprotinin and human recombinant R24K KD1 on temporal renal function in Long-Evans rats.

Authors:  Prakasha Kempaiah; Leslie A Danielson; Marc Barry; Walter Kisiel
Journal:  J Pharmacol Exp Ther       Date:  2009-09-23       Impact factor: 4.030

9.  Protective effects of recombinant kunitz-domain 1 of human tissue factor pathway inhibitor-2 against 2-chloroethyl ethyl sulfide toxicity in vitro.

Authors:  Moonsuk S Choi; Kalpana Parikh; Ashima Saxena; Nageswararao Chilukuri
Journal:  Eplasty       Date:  2007-12-03

10.  Human tissue factor pathway inhibitor-2 is internalized by cells and translocated to the nucleus by the importin system.

Authors:  Prakasha Kempaiah; Hitendra S Chand; Walter Kisiel
Journal:  Arch Biochem Biophys       Date:  2008-12-10       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.